[Anticoagulation and comorbidities]
MMW Fortschr Med
.
2020 Mar;162(5):36-44.
doi: 10.1007/s15006-020-0261-x.
[Article in German]
Authors
Clemens Jilek
1
,
Thorsten Lewalter
2
Affiliations
1
Peter Osypka Herzzentrum München, Internistisches Klinikum München Süd, Am Isarkanal 36, D-81379, München, Deutschland. forschung@jilek.de.
2
Peter Osypka Herzzentrum München, Internistisches Klinikum München Süd, Am Isarkanal 36, D-81379, München, Deutschland.
PMID:
32189262
DOI:
10.1007/s15006-020-0261-x
No abstract available
Keywords:
Atrial fibrillation; NOAC; anticoagulation; comorbidities.
Publication types
Review
MeSH terms
Administration, Oral
Anticoagulants* / adverse effects
Atrial Fibrillation*
Humans
Stroke*
Substances
Anticoagulants